4//SEC Filing
ONYX PHARMACEUTICALS INC 4
Accession 0001209191-07-061738
CIK 0001012140operating
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 2:50 PM ET
Size
8.9 KB
Accession
0001209191-07-061738
Insider Transaction Report
Form 4
KENNEY EDWARD F
EVP, Chief Business Officer
Transactions
- Sale
Common Stock
2007-11-01$46.29/sh−3,000$138,870→ 27,250 total - Exercise/Conversion
Stock Option (Right to Buy)
2007-11-01−3,000→ 28,000 totalExercise: $20.81Exp: 2015-08-31→ Common Stock (3,000 underlying) - Exercise/Conversion
Common Stock
2007-11-01$20.81/sh+3,000$62,430→ 30,250 total
Footnotes (2)
- [F1]Shares sold pursuant to a 10b5-1 plan.
- [F2]The shares vest monthly from the date of grant at a rate of 1/48th per month over a period of 48 months.
Documents
Issuer
ONYX PHARMACEUTICALS INC
CIK 0001012140
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001012140
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 2:50 PM ET
- Size
- 8.9 KB